Cutting Edge Research Group — Oklahoma City, Oklahoma

Cutting Edge Research Group is a clinical research site located in Oklahoma City, Oklahoma, United States 73116.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Cutting Edge Research Group has participated in 54 clinical trials with 1 currently active.

Therapeutic areas: Attention Deficit Hyperactivity Disorder, Insomnia, Autism Spectrum Disorder.

Sponsors: Sumitomo Pharma America, Inc., Hoffmann-La Roche, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cutting Edge Research Group?

Cutting Edge Research Group has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cutting Edge Research Group conducted?

Cutting Edge Research Group has 54 clinical trials on record, with 1 currently active. Their work covers Attention Deficit Hyperactivity Disorder, Insomnia, Autism Spectrum Disorder.

Is Cutting Edge Research Group accredited by Crixeo Clinical Trials?

Cutting Edge Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cutting Edge Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.